Skip to Main Content

Steven Hays

MD

Medical Director, Lung Transplant Program
Pulmonologist

Dr. Steven Hays, a pulmonologist, is medical director of the UCSF Lung Transplant Program, which is known for accepting patients with complex conditions while maintaining superior survival rates. His expertise is in caring for patients with end-stage lung disease who proceed through the lung transplant process. He treats conditions that include cystic fibrosis, emphysema associated with alpha-1 antitrypsin deficiency, and interstitial lung disease.

In research, Hays focuses on studying how airway remodeling occurs in the transplanted lung.

Hays earned his medical degree at the University of Kansas. He completed a residency in internal medicine at the University of Kansas Medical Center, where he served as chief resident, followed by a fellowship in pulmonary and critical care medicine at UCSF. He also completed a lung transplant fellowship at Stanford Health Care.

  • Education

    University of Kansas School of Medicine, 1995

  • Residencies

    University of Kansas Medical Center, Internal Medicine, 1998

  • Fellowships

    UCSF Medical Center, Pulmonary Medicine, 2003

    Stanford Hospital and Clinics, Lung Transplant, 2004

  • Board Certifications

    Pulmonary Disease, American Board of Internal Medicine

    Critical Care Medicine, American Board of Internal Medicine

  • Academic Title

    Professor

  • Languages

    Spanish

Where I see patients (2)

    My reviews

    5.0

    Overall Experience
    192 Ratings
    Explained things in a way that was easy to understand
    190 Ratings
    Did the doctor pay attention to your concerns
    190 Ratings
    Gave easy to understand instructions about taking care of health problems or concerns
    189 Ratings
    Knew the important information about your medical history
    190 Ratings
    The provider showed respect for what you had to say
    190 Ratings
    The provider spent enough time with me
    191 Ratings
    dr-steven-hays-md-103-1440x818-2x

    "We have patients who we’ve been following for over twenty years. We’re going to grow old together."

    Decorative Caduceus

    Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung...

    Recruiting

    Decorative Caduceus

    Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung...

    Recruiting

    Share